Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
Abstract Background The current study aimed to evaluate growth and neurodevelopmental status in patients with retinopathy of prematurity (ROP) treated with intravitreal bevacizumab (IVB). Methods This historical cohort study was conducted on neonates with ROP who were treated with IVB and age and bi...
Main Authors: | Majid Abrishami, Hassan Boskabadi, Mojtaba Abrishami, Farid Shekarchian, Majid Khadem-Rezaiyan, Nasser Shoeibi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-11-01
|
Series: | International Journal of Retina and Vitreous |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40942-021-00340-6 |
Similar Items
-
Association between severe retinopathy of prematurity (ROP) and poor motor neurodevelopmental outcome
by: Swathi Godugu, et al.
Published: (2023-01-01) -
Clinical report of intravitreal Bevacizumab for 26 cases with retinopathy of prematurity in Zone Ⅰ
by: Feng Chen, et al.
Published: (2016-07-01) -
Reactivation of retinopathy of prematurity after intravitreal bevacizumab monotherapy in aggressive posterior retinopathy of prematurity
by: Ritesh Verma, et al.
Published: (2023-01-01) -
Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment
by: Sadik Gorkem Cevik, et al.
Published: (2020-08-01) -
Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity
by: Shah Parag, et al.
Published: (2007-01-01)